Department of Intensive Care, Guy's and St. Thomas' NHS Foundation Trust, Westminster Bridge Road, London SE1 7EH, United Kingdom.
Resuscitation. 2010 Sep;81(9):1117-22. doi: 10.1016/j.resuscitation.2010.05.001. Epub 2010 Jul 4.
Therapeutic hypothermia (32-34 degrees C) is recommended for comatose survivors of cardiac arrest; however, the optimal technique for cooling is unknown. We aimed to compare therapeutic hypothermia using either surface or endovascular techniques in terms of efficacy, complications and outcome.
Retrospective cohort study.
Thirty-bed teaching hospital intensive care unit (ICU).
All patients (n=83) undergoing therapeutic hypothermia following cardiac arrest over a 2.5-year period. The mean age was 61+/-16 years; 88% of arrests occurred out of hospital, and 64% were ventricular fibrillation/tachycardia.
Therapeutic hypothermia was initiated in the ICU using iced Hartmann's solution, followed by either surface (n=41) or endovascular (n=42) cooling; choice of technique was based upon endovascular device availability. The target temperature was 32-34 degrees C for 12-24 h, followed by rewarming at a rate of 0.25 degrees Ch(-1).
Endovascular cooling provided a longer time within the target temperature range (p=0.02), less temperature fluctuation (p=0.003), better control during rewarming (0.04), and a lower 48-h temperature load (p=0.008). Endovascular cooling also produced less cooling-associated complications in terms of both overcooling (p=0.05) and failure to reach the target temperature (p=0.04). After adjustment for known confounders, there were no differences in outcome between the groups in terms of ICU or hospital mortality, ventilator free days and neurological outcome.
Endovascular cooling provides better temperature management than surface cooling, as well as a more favorable complication profile. The equivalence in outcome suggested by this small study requires confirmation in a randomized trial.
推荐对心脏骤停后昏迷的幸存者进行治疗性低温(32-34℃);然而,冷却的最佳技术尚不清楚。我们旨在比较使用表面或血管内技术的治疗性低温在疗效、并发症和结局方面的差异。
回顾性队列研究。
30 张床的教学医院重症监护病房(ICU)。
在 2.5 年期间经历心脏骤停后接受治疗性低温的所有患者(n=83)。平均年龄为 61+/-16 岁;88%的心脏骤停发生在院外,64%为室颤/室速。
在 ICU 中使用冰哈特曼溶液开始治疗性低温,然后使用表面(n=41)或血管内(n=42)冷却;技术选择基于血管内设备的可用性。目标温度为 32-34℃,持续 12-24 小时,然后以 0.25℃/h 的速度复温。
血管内冷却提供了更长的目标温度范围内的时间(p=0.02),更少的温度波动(p=0.003),在复温期间更好的控制(0.04),以及更低的 48 小时温度负荷(p=0.008)。血管内冷却还减少了冷却相关并发症,包括过度冷却(p=0.05)和未达到目标温度(p=0.04)。在调整了已知混杂因素后,两组在 ICU 或医院死亡率、无呼吸机天数和神经结局方面没有差异。
血管内冷却提供了比表面冷却更好的温度管理,以及更有利的并发症谱。这项小型研究表明的结果等效性需要在随机试验中得到证实。